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ABSTRACT 
IN  SITU DETECTION OF Tbx 5 EXPRESSION IN DEVELOPING EMBRYONIC 
CHICK HEART 
by Vaishali Agarwal 
The Tbx 5 gene codes for a highly conserved transcription factor containing a 
DNA-binding motif called the T box (or T-domain).  Tbx 5 is expressed in the posterior 
sinoatrial segment of the heart along with the developing forelimb buds.  Mutations in 
Tbx 5 gene are associated with Holt Oram Syndrome (HOS), which is characterized by 
heart septal defects and forelimb abnormalities.  Tbx 5 expression was examined during 
various stages of heart development in chick embryos using both a double stranded 
digoxygenin-labeled DNA probe and a single stranded digoxygenin-labeled anti-sense 
RNA probe (riboprobe).  Due to the presence of homology in the Tbx family, 
bioinformatics tools were used to design primers targeting specifically the Tbx 5 
transcript and not other Tbx family members.  During the course of this project, we 
conducted eight sets of whole mount in situ hybridization studies.  Various experimental 
parameters, including fixation conditions, hybridization stringency, and wash conditions, 
were studied thoroughly and optimizations were carried out.  We also examined the 
effects of the type and concentration of the probe upon the signal strength.  Our studies 
indicated intermediate levels of Tbx 5 expression in the inflow tract, with strong 
expression in the atrio-ventricular regions and left ventricular regions. 
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1-LITERATURE REVIEW 
1.1 Heart Formation: An Overview 
Heart formation is a highly complicated process in which a number of regulatory 
processes convert a group of cardiac progenitor cells into a complex network of 
specialized cells that make the adult four chambered heart (Drenckhahan, 2009).  During 
the various stages of heart development, there may be any number of signaling and/or 
gene regulation errors, the sum of which can lead to a broad constellation of congenital 
heart defects (CHD).  Approximately 1% of newborns are affected by some abnormality 
in heart formation (Hoffman and Kaplan, 2002), making heart abnormalities the most 
common forms of human birth defect.   This high frequency of heart abnormalities 
suggest to us that the various signaling and gene regulatory systems controlling 
cardiogenesis must maintain a sensitive balance if perturbations in morphogenesis are to 
be avoided.  The heart is, in fact, the first organ to function in the developing embryo, 
and it is physiologically critical that the heart start to functioning even before its 
morphogenesis is complete.   A diffusion based mechanism for tissue perfusion and 
waste/metabolite removal would, for example, prove rapidly inadequate by Hamburger 
and Hamilton (HH) stage 10-11 of embryonic development.  The changing functional 
demands on the heart force rapid morphological changes during development.  The 
system, by definition, is extremely sensitive, and sensitive systems tend to be error-prone. 
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Despite its obvious importance, we know little about the mechanisms underlying 
cardiogenesis.  While the anatomical process of embryonic heart development has been 
studied for nearly a century, the molecular processes driving that morphogenesis still 
remain largely unknown.  To address this disparity, various studies involving both 
vertebrates and invertebrates have been conducted over the past 25 years, providing at 
least some insight into the nature and functionality of the signaling pathways involved 
and elucidating to some degree the dynamic expression patterns of key regulatory genes 
involved in those pathways.  To provide a context for our work on Tbx 5, a brief 
overview of heart development will be presented here. 
1.1.1 Heart Tube Formation 
In the chick embryo heart development is initiated at the gastrula stage, around 
Hamburger and Hamilton stage 3 (Harris et al., 2002).  At this time cells from the 
primitive streak (the anatomical midline of the chick and the anterior/posterior embryonic 
axis marker) invaginate and migrate out under the definitive embryonic ectoderm layer.  
The migrating definitive endodermal cells displace the hypoblast (originally underlying 
the ectoderm), while the mesoderm cells invest between these two other layers.  This 
process thus forms the three primary germ layers of the embryo: the ectoderm, the 
endoderm, and the mesoderm.  Just prior to gastrulation, those cells that will ultimately 
give rise to the primary heart field appear to be localized initially to the cranial third of 
the primitive streak, immediately caudal to Hensen’s node.  During gastrulation they 
invaginate at the primitive streak and migrate out as part of the lateral plate mesoderm 
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(Fishman et al., 1997, Moorman et al., 2003).  Soon thereafter (or possibly simultaneous 
with migration), the mesodermal layer splits into an upper somatic mesodermal layer 
(adjacent to and overlying the ectoderm) and a lower splanchnic mesodermal layer 
(adjacent to and underlying the endoderm), with a thin cavity, or intraembryonic coelom, 
separating the two mesodermal layers.  At this time the underlying endoderm is thought 
to secrete a number of different signaling factors (especially Bone Mophogenetic Proteins 
[BMP], Fibroblast Growth Factors and Sonic Hedgehog), with BMPs (members of the 
Transforming Growth Factor beta family) thought to play a key role in initially 
specifying the adjacent overlying splanchnic mesoderm as “cardiogenic” mesoderm 
(Drenckhahan, 2009, Schoenwolf et al., 2009, Alsan and Schultheiss, 2002, Gilbert, 
2006).  Simultaneously, the notochord and developing neuroectoderm (midline structures 
in the embryo) secrete BMP antagonists like Chordin and Noggin (which sequester BMPs 
and prevent their action) and Wnts (which exhibit a signal transduction system that 
antagonizes that of the BMPs).  Under the influence of these spatially restricted and 
opposing signaling factors, an “inverted U-shaped” domain of cardiogenic splanchnic 
mesoderm develops (the primary heart field or “cardiac crescent”), with the two thick 
arms of the inverted U in the upper and middle lateral plate, linked by a thin region 
cranial to the developing neural plate (Harvey, 2002, Ramsdell et al., 2005).  The 
unopposed BMPs in the cardiac crescent region then stimulate expression of a number of 
transcription factors, with Nkx 2.5 and Gata 4 being prominent and thought important in 
the continuing cardiac specification of the mesoderm (Berg et al., 2009, Searcy et al., 
1998).  In addition, the production of retinoic acid (RA), secreted as a gradient by the 
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developing posterior mesoderm, is thought to help “regionalize”  the caudal portion of the 
developing heart field, driving the posterior cardiac precursors to a more “inflow” or 
“venous” specification (Gilbert, 2006). 
Up to this point the embryonic plate could be essentially described as a flat, ovoid 
disc.   After this time, however, the overall structure of the embryo starts to change 
dramatically.  Forward growth of the developing neural plate causes a flexion or bending 
at the oropharyngeal region (a domain just cranial to the neural plate that possesses no 
mesoderm and is thus quite thin) and starts to swing the cranial-most portion of the 
embryonic disc (that region anterior to the neural plate) down toward the future chest.  
Simultaneously, the lateral portions of the embryonic disc flex sharply inward ventrally 
towards the midline.  As a result of these embryonic folding events, the two lateral 
domains of the cardiac crescent are also swung in ventrally towards the midline.  As the 
two lateral domains are swung together, however, vasculogenesis occurs in each domain, 
giving rise to two endocardial tubes.  These tubes then ultimately meet and fuse in the 
midline (occurring abound stage HH10 in the chick), producing the definitive heart tube 
(Harris et al, 2002).   
The definitive heart tube soon develops a number of layers: (i) an inner 
endocardial tube (an endothelial layer bounding the lumen of the heart tube), (ii) an outer 
layer of cadiomyogenic progenitors that form the myocardium (muscular portion of the 
heart), and (iii) an intervening layer of extracellular matrix termed cardiac jelly 
separating the two cellular layers (Figure 1).  Only later will the epicardial layer of the 
heart develop to cover the myocardium, as will be discussed below.  
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Fig. 1.  Anatomical representation of the heart tube. Figure adapted from Armstrong and 
Bischoff, 2004 with permission from Wolters Kluwer Health. 
 
Throughout this time the continued expression of Nkx 2.5 and Gata 4 drive the 
expression of a number of other transcription factors important in cardiogenesis, 
including Mef2, dHand, eHand, and a number of Tbx family members (including the 
continued expression of Tbx 5) (Berg et al, 2009, Plageman and Yutzey, 2005). 
Not all of the cardiac cells found in the mature heart, however, are derived from 
the primary heart field.  The cells giving rise, for example, to the epicardium (the third, 
outermost cellular layer of the heart), the coronary endothelium (or at least the majority 
of it), and the associated smooth muscle cells supporting the coronary vasculature appear 
to arise from a special domain called the proepicardial organ (Munoz-Chapuli et al, 
2002).  Furthermore, additional cardiogenic precursors are recruited from the mesoderm 
immediately adjacent and medial to the initial cardiac crescent, a domain now referred to 
as the secondary heart field (Schoenwolf et al, 2009, Buckingham et al, 2005).  It is 
currently thought that the primary heart field gives rise to the right and left atria and the 
left ventricle, with only light cellular investment in the right ventricle and outflow tract 
structures.  The secondary heart field, in contrast, is thought to form the majority of right 
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ventricle, outflow tract and the posterior-most portions of the venous pole (Schoenwolf et 
al., 2009).  It is currently unclear whether the proepicardial organ is a portion of the 
secondary heart field or an independent third field. 
1.1.2 Cardiac Looping 
As has been mentioned previously the heart starts pumping blood even before its 
morphogenesis is complete, actually around the time of definitive heart tube formation 
(Gilbert, 2006).  Looking at an embryonic heart beating at an early stage gives an 
impression of the presence of two separate blood streams in the heart tube. This is 
because of the asymmetric contractions (Moorman, 2003). As shown in Figure 2, the 
symmetric arms of the heart tube form the primary atrial component, a subdomain of 
which ultimately participates in the formation of the atrioventricular canal (Moorman, 
2003). 
 
Fig. 2. Mouse embryos with 4, 6 and 8 somites. Blue color indicates myocardium. The 
yellow arrow indicates the cells fated to be atrio ventricular canal. Figure adapted from 
Moorman et al., 2003 and reprinted with permission from BMJ Publishing Group Ltd. 
 
The tubular heart ultimately develops into a complex four chambered heart via the 
combined processes of cardiac looping and septation, with the former process taking 
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place around HH stage 10 through to stage 18 (Manner, 2000).  As shown in Figure 3, 
during the initial steps (spanning stage HH10 to late HH12) the heart tube bends 
rightward into a “C- shaped” loop, clearly defining the sinus horns and sinus venosus 
region (at the posterior pole of the heart), a common atrial domain, a large ventricle 
(which give rise to the definitive left ventricle), a much smaller and tapering bulbus 
cordis (which will ultimately form most of the right ventricle), and (at the anterior pole) 
an outflow track with a prominent conus arteriosus (Moorman, 2003; Saber et al., 2008).  
During this stage the ventricular regions develops a bulging towards the right, and is the 
first anatomical manifestation of left/ right symmetry in the vertebrate embryo (Voronov, 
2004).  As the heart tube continues to elongate at both the venous and arterial poles, it 
later bends and twists into a “S- shape” (Manner, 2009), which serves to swing the 
common atrial region up and the ventricular region down, placing the ventricular region 
below the atria as in the basic plan of the adult heart (a process spanning about stage 
HH13 to 18).  The genes involved in specifying the 4 chambers are still under intense 
investigation, but probably involve Nkx, Gata and TBX family members, Hand genes, 
Xin, flexin and Pitx2, among others (Schoenwolf et al., 2009; Gilbert, 2006).  The end 
result of cardiac looping is to bring the four presumptive chamber domains of the future 
heart into their correct spatial relationship relative to each other. 
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Fig. 3. Overview of stages of cardiac looping in chick heart development. Figure adapted 
from Manner 2009 and reprinted with permission from John Wiley and Sons Inc. 
 
Following looping, the remainder of heart development consists basically of expansion 
and remodeling of the chambers, developing the appropriate septa (walls) and valves 
between them, creation of the epicardium and coronary vasculature, forming the cardiac 
conduction pathways and establishing connections with the peripheral nervous system.  
While we consider it beyond the scope of this brief review to discuss all those subsequent 
processes, at least some description of septation and valve development is in order, given 
the possible involvement of Tbx 5 in their formation (Bruneau et al., 1999). 
1.1.3 Heart Septation 
  The division of the heart into 4 distinct and separate chambers is a highly 
complex developmental process.  Localized (“differential”) growth and tissue remodeling 
are thought to be mainly responsible for creating the muscular interventricular and 
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interatrial walls (septa) of the heart, while endocardial-derived and neural crest-derived 
cushion tissue formation and remodeling appear to be the principle mechanisms for 
creation of the valves and for septation of the outflow tracts (Schoenwolf et al., 2009).   
The process of atrial septation begins with the highly localized growth of a thin 
plate-like ridge of tissue in the cranial-dorsal roof of the atrium, extending downward into 
the common atrium as a crescent shaped wedge referred to as the septum primum 
(Larsen, 2001).   As development proceeds, the septum primum grows further, extending 
towards the common atrioventricular canal, separating the common atrium into right and 
left atrial chambers and creating a progressively diminishing opening termed the foramen 
primum or ostium primum (Larsen, 2001).  During the growth of the septum primum, 
four endocardial-derived thickenings (termed endocardial cushion tissues) develop 
around the periphery of the common atrioventricular canal: large dorsal (or superior) and 
ventral (or inferior) cushions, and smaller right and left cushions.  The large dorsal and 
ventral endocardial cushions eventually meet and fuse to form the atrioventricular septum 
(or septum intermedium) which divides the common atrioventricular canal, thereby 
creating a left and right atrioventricular canal.  With the eventual fusion of 
atrioventricular septum  and growing septum primum, the ostium primum is finally 
obliterated (closes) but not before programmed cell death in a cranial-dorsal region of the 
septum primum creates another foramen (opening) referred to as the foramen secundum 
(or ostium secundum).  This foramen secundum thus continues to allow for the “right to 
left” shunting of blood between the two atria needed for proper chamber development 
(Larsen, 2001). 
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Intra-atrial sepation, however, is still incomplete.  While the septum primum is 
still growing towards the atrioventricular septum a second ridge of tissue forms on the 
ceiling of the right atrium and extends downward, just adjacent and to the right of the 
septum primum.  In contrast to the septum primum, this septum secundum is a thick and 
muscular plate.  It too grows to create a wall separating the two atria, but before it 
reaches the atrioventricular septum it stops, leaving a hole called the foramen ovale near 
the floor of the right atrium.  Even at this point the “right to left” shunting of blood 
between the two atria can thus continue, as contraction of the right atrium can send at 
least some blood through the foramen ovale of the septum secondum, through the 
foramen secondum of the septum primum, and finally into the left atrium.  This shunt 
will in fact continue to operate throughout the remainder of fetal development, normally 
closing only at birth (Larsen, 2001). 
Simultaneous with the process described above, other regions of the heart are also 
undergoing massive remodeling.  The common atrioventricular canal, for example, must 
be repositioned by a rightward shift, allowing the alignment of the future left and right 
atrioventricular canals with their respective atria and ventricles (Larsen, 2001).  No less 
importantly, the primitive ventricle and bulbus cordis must be remodeled into left and 
right ventricular primordial (respectively) as the intraventicular septum begins to form. 
Formation of the thick muscular wall giving rise to separate right and left 
ventricles begins with a slowly elongating ridge known as the muscular interventricular 
septum (Waldo, 1998; Larsen, 2001).  This wall, even initially quite thick at its base, 
grows upward to eventually create and separate the two ventricular chambers. 
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Simultaneously, the ventricular myocardium begins to thicken and form trabecule 
(myocardial ridges) on the inner walls of both ventricles. Growth of the muscular 
interventricular septum up to the central atrioventricular septum is not continuous 
however, but is arrested when it has only grown about half-way up.  This temporary 
cessation (or at least profound slowing) of growth is necessary, since fusion with septum 
intermedium too soon would render the left ventricle totally shut off from the ventricular 
outflow tract (Larsen, 2001).  
With growth of the interventricular septum arrested, development of the 
atrioventricular valves begins.  The valves are thought to arise from proliferation and 
differentiation of endocardial cushion tissue surrounding the lumen of each 
atrioventricular canal.  The valve leaflets are thought to be freed from the wall by 
remodeling, while adjacent regions of the myocardial wall are freed (also via remodeling) 
to create thin, strand-like chordae tendineae and small cones of myocardium called 
papillary muscles. 
Around this time the cardiac outflow tract becomes divided via the formation of a 
pair of endocardial and neural crest cell-derived conotruncal ridges that grow inward in a 
roughly spiral pathway along the length of the conotruncal segment.  These ridges 
eventually grow together and fuse, creating two separate outflow tract tubes (the 
proximal portions of the aorta and pulmonary artery).  Simultaneously, those conotruncal 
ridge segments also expand as a downward growing plate to eventually fuse with the 
muscular ventricular septum, finishing the wall separating the right and left ventricles and 
giving rise to separate right and left ventricular outflow pathways.  Also at this time, two 
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smaller additional masses of cushion tissue (the intercalated cushion tissues) form at the 
base of the outflow tract and, via remodeling, give rise to the semilunar valves.   
While no intent was made here to make this an exhaustive review, hopefully 
enough background has been provided to give our work on Tbx 5 some context.   Prior to 
discussing Tbx 5 and the Tbx gene family, however, it seems appropriate to present at 
least a brief rationale regarding the of use of the chick as an experimental model.   
 
1.2 The Chick as an Experimental Model in the Study of Heart Development 
 Use of the chick (gallus gallus) embryo as an experimental model for 
developmental studies dates back to 300 B.C. where the Egyptians performed the first 
scientific study of embryo development, work which was continued by researchers like 
Aristotle who studied the morphology of the chick embryo (before the invention of 
magnifying devices) (Stern, 2004).  Leonardo Da Vinci (who lived from 1452-1519) and 
Ulisse Aldrovandi (who lived from 1522-1605) studied the anatomy of the embryonic 
chick within the developing egg (Stern, 2004).  William Harvey studied the early 
developmental stages of the chick embryo and concluded that heart was the first 
functioning organ in the developing embryo (Stern, 2004).  
Organisms like the fruit fly (Drosophila), Zebrafish, the toad Xenopus, chick and 
mice are all currently used to study cardiogenesis, in large part because the molecular 
pathways involved in heart development demonstrate an often remarkable degree of 
conservation, making the findings broadly applicable.  That said, the mouse is probably 
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generally considered the premier model system, with the principle advantage being 
sophisticated genetics... inbred strains, the capacity to isolate and manipulate embryonic 
stem cells with the powerful ability to create animals with specific gene knockout 
constructs.  Chick embryos, however, present a number of advantages over most other 
“model organisms” used to study cardiogenesis, especially when the interest is 
specifically directed to development of the four chambered heart.  In brief, fertile chick 
eggs (and thus chick embryos) are very inexpensive and available throughout the year, 
are cheaply and easily reared (requiring a minimum of equipment, facilities, per diem 
charges and animal husbandry on the part of the investigator), are translucent enough 
early in cardiogenesis to allow direct observation of blood flow in the beating heart, are 
large in size (making stereomicroscopic observations, harvesting and any surgical 
manipulation much easier), and are genetically very complex (carrying about as many 
genes as the mouse or human, and exhibiting most of the same genetic regulatory 
systems, signaling and metabolic pathways).  Unlike insects, nematodes, fish, 
amphibians, and reptiles, avians possess a true 4 chambered heart, essentially identical to 
that found in mice and humans.  This advantage alone is often sufficient to justify its use.  
When compared to placental animals, chick embryos are infinitely more convenient for 
surgical resection, ablation, transplantation, and microinjection (or most other forms of 
microsurgical manipulation), as well as electroporation, lipofection, or infection with 
recombinant virus for protein or RNA expression, in vivo cell movement or cell lineage 
studies.  The chicken embryo can be removed from the shell and cultured for a short time 
span in a dish (usually 2 days at most) to facilitate manipulation, or can be incubated in 
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the egg (in ovo) to any desired stage of development.  The egg shell may be left intact 
throughout development or it may be “windowed” (in which a small hole is cut in the egg 
shell, a sterile glass cover slip placed over the hole and the cover slip sealed to the shell) 
to allow continuous visual monitoring of the developmental process.  The pre- and post-
gastrulation stages of the chick are well studied and characterized (greatly facilitating 
estimation of the developmental stage and the presence of developmental defects), and 
there is a vast store of developmental literature involving the chick (spanning nearly 100 
years) upon which to draw.  For these reasons the chick remains a heavily used 
experimental model for the study of cardiovascular system development (especially heart 
development) in higher vertebrates. 
1.3 A Brief Overview of the Tbx Family and Structural Characteristics 
On a historical note, the T-box gene family’s name is derived from work 
originally initiated in the 1920s at the Pasteur Institute by the Russian scientist Nadine 
Dobrovolskaia-Zavadskaia, carrying out a radiation-induced genetic screen for mutant 
developmental phenotypes in the mouse.  She identified one phenotype associated with a 
stunted tail, and mapped the gene to what she termed the “T locus.”  She named the gene 
Brachyury (Greek for “short tail”), but the “T” designation remained (Dobrozolskia-
Zavadskia, 1927, reviewed in Korz and Grunwald, 2001).  About 60-65 years later the 
Brachyury gene was cloned and found to possess a DNA sequence stretch that came to be 
called the “T-box.”  Within the next decade a number of genes were identified that 
carried a similar “T-box” sequence, and the T-box gene family was realized. 
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All the Tbx  gene family members identified to date encode  transcription factors, 
all related and defined by the presence of a highly conserved protein motif called the “T-
domain” (encoded by the T-box), involved in DNA binding and protein dimerization 
(Minguillon and Logan, 2003).  The genes in this family appear to be broadly conserved 
evolutionarily (Wilson and Conlon, 2002), with expression found in organisms ranging 
from insects, through nematodes, to fish, birds and mammals.  Most of the T-box gene 
loci appear to be dispersed randomly throughout chordate genomes (human T-box genes 
are found, for example, on chromosomes 1, 2, 3, 6, 7, 12, 16, 17, 22, and X), probably 
arising by gene duplication and subsequent cluster dispersion (Wilson and Conlon, 2002, 
King et al., 2006).  While the function of the various Tbx family members is currently 
being intensely investigated in many different organisms by a great number of 
laboratories world-wide, in broad sweep we now recognize that they play important roles 
in embryonic development across a number of organs and tissues, with individual family 
members often operating on many different target tissues.  
The general structure of a T-box protein appears to be: (i) a N-terminal domain 
(possibly exhibiting cofactor-binding function), followed by (ii) the T-domain (exhibiting 
DNA binding and dimerization functions), followed by (iii) a region containing a nuclear 
localization domain, and (iv) a C-terminal region containing a transcriptional activator or 
repressor domain (Minguillon and Logan, 2003,  Wilson and Conlon, 2002).  T-box 
genes all contain multiple exons, with the T-domain itself being generally encoded by at 
least five exons (Wilson and Conlon, 2002).  The exon structure for the various T-box 
gene family members can, however, vary considerably.  Entrez analysis of the human Tbx 
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5 gene, for example, reveals it to contain eight exons distributed over about 53 kilobases 
(kb) along chromosome 12.  Despite this variability in gene structure, however, 
homology within the T-domain between the various T-box proteins still averages 
approximately 70%.  It can be significantly higher though, as the T-domains of Tbx 4 and 
Tbx 5, for example, share 93% identity (Tada and Smith, 2001).  Proteins encoded by the 
20 different T-box genes currently known to exist in the vertebrate genome range from 
around 50 kiloDaltons (kDa) to 78 kDa in size, of which no small part (an average of 
approximately 180 amino acids, ranging about 17-26 kDa) comprises the T-domain itself 
(Ghosh et al., 2009, Bollag et al., 1994, Wilson and Conlon, 2002, Tada and Smith, 
2001).  While the original experiments with the Brachyury (T) protein revealed that it 
bound preferentially to the consensus sequence T(G/C)ACACCT-AGGTGTGAAATT 
(note the palindromic region underlined)  as a monomer, it was hypothesized that it might 
bind as a dimer in vivo (Kispert and Herrmann, 1993).  Subsequent work has shown 
Brachyury can also bind as a monomer to the T-half site AGGTGTGAAATT (King et al., 
2006) or the half-palindromic sequence (T/C)TTCACACCT (Casey et al., 1998).  Further 
studies have since revealed that all T-box proteins can bind to T-half sites as monomers 
(King et al., 2006), raising the possibility that target specificity might be generated, at 
least in part, by: (i) variations in half-site DNA sequence, allowing for differential 
binding by monomeric and/or homodimeric T-box proteins due to affinity differences for 
the site, and/or (ii) the formation of heterodimeric T-box proteins binding to different but 
adjacent half-sites.  A third, and independent, mechanism for generating T-box specificity 
could also involve protein-specific interaction with coactivators or corepressors, a 
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possibility bolstered by the observation that T-box proteins demonstrate synergistic 
activation of target genes when coexpressed with specific homeodomain, GATA zinc 
finger or LIM domain-type transcriptional regulators (Hiroi et al., 2001, Garg et al, 2003, 
Krause et al., 2001, topic also reviewed in Naiche et al., 2005). 
 As has been mentioned previously, the T-box proteins are involved in a variety of 
developmental processes.  Of the 20 Tbx genes currently identified in the human, at least 
6 are now associated with well known developmental disorders (Ghosh et al., 2009).  
Mutations in Brachyury (T), for example, are associated with spinal cord defects, 
mutations in Tbx 1 associated with velo-cardiofacial (DiGeorge) syndrome (a disorder 
characterized by absence or hypoplasia of the thymus, cleft palate, facial dysmorphism 
and such cardiovascular abnormalities as hypoplasia of the 4th pharyngeal arch artery, 
outflow tract defects and ventricular septal defects) (Baldini, 2004), mutations in Tbx 3 
associated with Ulnar mammary syndrome (a disorder characterized by hypoplastic 
mammary glands, abnormal external genitalia and limb abnormalities), mutations in Tbx 
4 associated with Small Patella syndrome (characterized by hip, knee and foot defects), 
and mutations in Tbx 5 associated with Holt-Oram syndrome, characterized by upper 
limb defects, atrial and ventricular septal defects and conduction system defects including 
AV block (reviewed in Naiche et al., 2005, Stennard and Harvey, 2005).  As suggested 
by the brief description above, many (but not all) of the disorders associated with 
mutations in T-box genes give rise to defects in skeletal (especially limb) formation 
and/or heart development.  Tbx 2, 3, 4, 5, 15 and 18, for example, are expressed in 
specific (though often overlapping) regions of  the limb buds, while Tbx 1, 2, 3, 5, 18 and 
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20 are currently thought to be similarly expressed in unique but overlapping regions of 
the developing heart (reviewed in Naiche et al., 2005; Stennard and Harvey, 2005).  
Important also is the fact that any given Tbx gene might be expressed in a wide variety of 
tissues during development.  Tbx 5, for example, is expressed (and known to play a 
crucial role) in the development of heart and forelimb, but is also at least transiently 
expressed in the dorsal side of the retina (Koshiba et al., 2000), the optic vesicle, the otic 
vesicle (Takeuchi et al., 2003), the genital papilla and the lung buds (Brown et al., 1998), 
and presumably plays developmental roles in those tissues as well.  Nor is Tbx 5 unique 
is this regard.  In situ hybridization studies on Tbx 2 have also indicated at least transient 
expression in both limb buds, various regions of the heart and aortic sac, the optic and 
otic vesicles, the dorsal root ganglia and duodeum (Brown et al., 1998).  Similar studies 
of Tbx 18 have revealed at least transient expression in the epicardium of the heart, the 
proepicardial serosa, the somites, the emerging forelimb and the developing urogenital 
system (Haenig and Kispert, 2004), while Tbx 20 has been reported in the primitive 
streak, the posterior lateral mesoderm and cardiac crescent, the endocardium and 
myocardium of the linear and looped heart tube, the ventricle and atrioventricular canal 
of the multichambered heart, the optic vesicle, the allantois, ventral neural tube and the 
hindbrain (Iio et al., 2001).  In fact, it appears that essentially all the Tbx family members 
are expressed in a variety of tissues at various times during development.  In the face of 
this almost unfathomable extent of developmental involvement across the entire Tbx 
family, it seems reasonable to select one key gene with a well known, clinically definable 
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role in cardiogenesis and examine in detail its expression pattern and, ultimately, its 
interaction partners, downstream targets and regulation.  We have selected Tbx 5. 
 As stated above, Tbx 5 is known to be absolutely required for normal 
development of the forelimbs and heart (Takeuchi et al, 1999).  Forelimb buds will not, in 
fact, even form in the absence of Tbx 5 (King et al, 2006), and the associated cardiac 
malformations can be profound.  Holt-Oram syndrome (HOS), like many human 
diseases, is actually a spectrum of phenotypes due to allelic variation at the Tbx 5 locus 
(Fan et al., 2003).  HOS is caused by a variety of mutations in the C-terminal half of the 
Tbx 5 gene, encompassing translocations, frame shifts, nonsense and missense mutations, 
and mutations giving rise to altered splice sites (Zaragoza et al, 2004), and the resultant 
effects of those different mutations can give rise to a spectrum of clinical presentations.  
The more severe forms of Holt-Oram syndrome (involving incapacitating atrial and/or 
ventricular septal defects, sinus node dysfunction and variable degrees of AV block, up to 
complete AV block) certainly attest to the requirement for Tbx5 in cardiogenesis 
(Newbury-Ecob et al, 1996; Basson et al., 1997; Hatcher and Basson, 2009).  Indeed, 
typically Tbx 5 null mouse embryos do not survive past embryonic day 10.5 (Bruneau et 
al., 2001).  Yet, while the importance of Tbx 5 in cardiogenesis seems beyond question, 
its functional interaction partners, transcriptional regulation, target genes and even 
expression domains remain either controversial or only vaguely understood.  Work by 
Ghosh et al (2001), for example, succeeded in deriving a minimal DNA octomer 
consensus sequence [(A/G)GGTGT(C/G/T)(A/G)] for which Tbx 5 demonstrates 
reasonably stable binding.  The presence of 3 variable base positions in this short 
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oligonucleotide stretch, however, makes it difficult to identify bona fide Tbx 5 binding 
sites in promotors (or more distal upstream regions) of putative target genes.  Work in 
identifying Tbx 5 interaction partners has gone better.  Hiroi et al (2001), for example, 
presented convincing evidence that Tbx 5 can associate with Nkx2-5 and that the 
association could drive cardiomyocyte differentiation in a synergistic fashion.  Soon 
thereafter, Garg et al (2003) presented evidence for a Tbx 5: GATA 4 interaction. These 
interactions appear quite important, given that both Nkx2-5 and GATA 4 are expressed 
throughout cardiogenesis and that mutations in these genes are well known to produce 
heart defects during development. These interaction studies were then followed by the 
work of Krause et al (2004), who presented evidence for a physical association between 
TBX 5 and a PDZ-LIM protein (LMP-4) in the heart, by Brown et al (2005), who found 
evidence for an association between Tbx 5 and Tbx 20, and by Koshiba-Takeuchi et al 
(2006), who demonstrated interactions between Tbx 5 and Sall4 in the heart.  The 
interaction between TBX 5 and TBX 20 (at the very least) appears significant in light of 
the fact that: (i) Tbx 20 is expressed in the developing heart, and (ii) mutations in mouse 
Tbx 20 have produced documented heart defects (Stennard et al, 2005).   Most recently 
Ghosh et al (2009) provided evidence for a physical interaction between Tbx 5 and 
MEF2C.   This is potentially very important given the ability of MEF2 family members 
to associate with myogenic bHLH protein like MyoD, myogenin, Myf5 and MRF4 to 
regulate muscle differentiation (Bour et al, 1995; Black and Olson, 1998).  Despite this 
progress in identifying Tbx 5 interaction partners, however, we are only now gaining an 
understanding of the target genes these transcription factors (or combinations of factors) 
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actually regulate.  Tbx 5 upregulation followed by measurement of changes in gene 
expression can identify potential Tbx 5 target genes, and work of this type (Plageman and 
Yutzey, 2006; Lu et al, 2008) suggests the following as Tbx 5 targets: (i) Nappa 
(natriuretic peptide precursor A), (ii) fgf10 (fibroblast growth factor 10), (iii) Cx40 
(connexin 40), (iv) pla2g2e (phospholipase A2, group II E),  (v) hey2 (hairy/enhancer of 
split-related 2), (vi) amhc (atrial myosin heavry chain), (vii) gelsolin and (viii) CKB 
(creatine kinase, brain) being the more prominent.  Detecting an increase in transcript 
abundance of a gene following Tbx 5 expression, however, does not actually prove that 
Tbx 5 directly binds to the promoter/regulatory region of that gene to induce its 
transcription.  For proof of the ability of Tbx 5 to directly bind to a promoter and induce 
that specific target gene, reporter construct experiments and electromobility shift assays 
are usually required and, to date, these confirmatory experiments have been carried out 
for only a few of the genes cited above.  Finally, there is still controversy regarding the 
pattern of Tbx 5 expression in the developing heart as a function of developmental stage.  
According to researchers like Bruneau et al. (1999) and Takeuchi et al. (2003), Tbx 5 is 
expressed only in the left ventricle and not in the right ventricle. Bimber et al. (2007), 
however, report the expression of Tbx 5 in the right ventricle along with the left ventricles 
(Fig. 36).  They performed immunohistochemical studies on embryonic chick heart and 
report strong expression of Tbx 5 in the left ventricle and atria, but also low to moderate 
expression in the right ventricle.  This conflict is further compounded by the fact that the 
vast majority of papers reporting in situ results fail to present their hybridization 
methodology (especially with regards to probe characteristics, probe concentration, 
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hybridization/wash stringency conditions, etc.) or their probe sequences.  Given the high 
degree of sequence similarity between the various Tbx family members, it is quite 
possible that at least some of the reportedly “specific” signal might in fact be due to 
cross-hybridization of the probe with transcripts encoding other Tbx family members... 
either as a result of inappropriately chosen hybridization conditions or inappropriate 
probe design.  To address these problems, we embarked on a project that involved 
rational, Tbx 5-specific probe design and a detailed optimization of our in situ 
hybridization methodology. 
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2- METHODOLOGY 
 
2.1 Embryo Extraction 
 
 2.1.1 Incubation of Fertile Eggs 
Fertile eggs were obtained from Cal Cruz Hatcheries Inc, Santa Cruz, CA.  Since 
the eggs were “cool stored” by the hatchery operators very soon after fertilization, for 
practical purposes such eggs were considered to be at “day 0” of incubation.  The eggs 
were then transported rapidly back to our laboratory at SJSU for immediate placement in 
a humidified, 37.5 oC incubator fitted with an automatic egg turner.  The incubator’s 
internal reservoir was filled with water and the electric heater/fan assembly switched on 
at least 2 hrs prior to use, the eggs placed in the trays in the “air sac up” position (Fig. 4) 
and eggs then allowed to incubate.  The incubator humidity was maintained by filing up 
the internal water reservoir as needed (typically every other day), and the egg turner (run 
by a small electric motor) slowly rotated the eggs across an arc of about 90º every hour 
(to minimize adhesion of embryos to the egg shell inner membranes).  Our experience 
suggests that, with our incubation system, there is some initial “lag period” in the 
resumption of development.  To obtain “3 day old embryos,” for example, eggs were 
often incubated for 3 days and 4 nights.   
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Fig. 4. Photograph of fertile eggs in the lab incubator.  The clear Lucite observation 
window and thermometer and humidity gauges (visible at the back wall of the incubation 
chamber) allowed easy monitoring of the incubation conditions. 
 
2.1.2 Embryo Harvest 
Embryo harvest was performed in an aseptically prepared (cleaned and 70% 
ethanol rinsed) surgical area (Fig. 5).  The surgical instruments (forceps, scissors, and 
spatulas) were sterilized repeatedly as needed by immersion in 70% ethanol and flaming 
over an alcohol lamp.  Liquid reagents used in the harvest (typically just deionized [DI] 
water and 1X phosphate buffered saline [PBS]) were sterilized by autoclaving.  The eggs 
were placed in a holder (a bottle cap often worked well), oriented “air sac end” up, and 
the egg shell wiped clean with a 70% ethanol-soaked Kimwipe.  
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Fig. 5. Demonstration of embryo harvest being done by Dr. Steven White, photographed     
by Sureetha Ashokan. 
 
Blunt-ended forceps were then used to punch a small hole in the egg shell, and 
that portion of the shell overlying the air sac was removed.  The white shell membrane 
and associated chorioallantoic membrane were then carefully removed to expose the 
embryo for stereomicroscopic observation, assessment of the developmental stage, and 
further processing (Fig. 6). 
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Fig. 6. Photograph of embryo in the egg after removal of the overlying membranes and 
just prior to isolation, still connected by the vascularized Vitelline membrane. 
 
A scissors was used to cut the embryo carefully away from most of the underlying 
highly vascularized (Vitelline) membrane, and a spoon-shaped spatula was used to 
transfer the embryo into a sterilized plastic Petri dish containing autoclaved 1X PBS.  If 
needed, any adhering yolk particles were rinsed off the embryo and the embryo 
transferred to a new dish containing sterile PBS.  Using a dissecting microscope, small 
surgical scissors, and a narrow-bladed scalpel, the more tightly associated membranes 
were then removed from around the embryo.  For most embryos the brain cavity was 
opened (typically either by cutting or poking through one or both telencephalic 
hemispheres or by poking a hole in the neural tube at the level of the diencephalon) to 
minimize background signal due to probe and/or antibody trapping.  If needed, embryos 
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were then transferred to yet another Petri dish containing 1X PBS to wash away any 
residual yolk or membrane/tissue fragments (Fig. 7).  
 
Fig. 7. Photograph of the embryo after all the membranes are removed, prior to fixation. 
 
2.2 Whole Mount In Situ Hybridization 
2.2.1 Fixation 
Each embryo was transferred to a 20 ml glass liquid scintillation counter vial 
containing 10 ml freshly prepared cold 4% paraformaldehyde in 1X PBS (PFA).  It is 
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extremely important that PFA should be fresh, prepared typically 1.5 hours prior to 
initiating harvest of the embryos.  Fixation was done overnight at 4ºC.  
2.2.2 Dehydration 
Each embryo was dehydrated in a series of freshly prepared 5 ml methanol/PBS 
solutions (25%, 50%, 75%, 90% and 100%) for 15 minutes each. Following this series, 
the embryos were dehydrated twice in 100% methanol.  For rehydration, a methanol 
gradient was prepared using 100% methanol, PBS and 0.1% Tween 20 (PBT).  A P1000 
(1000µl) pipettor was used to add and remove the methanol/PBT solution.  Extreme care 
was taken while removing the solution as the embryos were very fragile and could be 
aspirated into the pipet and be destroyed.  Any remaining solution was removed using a 
Pasteur pipet.  
2.2.3 Rehydration 
Each embryo was rehydrated in a downward methanol: PBT gradient (90% 
methanol twice, 75%, 50%, 25%, 10% methanol + PBT and thrice in 100% PBT) using 
the above described methodology for 15 minutes on ice at each step.  Embryos were very 
carefully transferred from the scintillation vial to a 48 well plate using a soft sable brush 
2.2.4 Proteinase K Digestion 
Each embryo was placed in 1 ml of PBT containing Proteinase K (4.5 µg/ml) for 
30 minutes.  The digestion was stopped by washing the embryos in freshly prepared 2 
mg/ml glycine in PBT.  Embryos were further washed twice in PBT for 5 minutes each. 
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2.2.5 Secondary Fixation 
Embryos were refixed in 5 ml of 4% PFA and 0.2% Glutaraldehyde in PBT for 15 
minutes.  Embryos were washed thrice in PBT for 5 minutes each. 
2.2.6 Prehybridization 
Embryos were placed in 900 µl prehybridization solution at 65° C for 3 hours. 
The 48 well plates was sealed using parafilm. 
Fifty ml of prehybridization solution  was prepared as follows by first mixing 0.5 
g Boehringer blocking powder, 25 ml of  deionized formamide and 12.5 ml of 20X SSC 
(3M NaCl, 0.3M NaCitrate, pH 7.0 ) at a pH 7 together, then heated at 65°C for 1 hour, 
after blocking powder dissolves, 6 ml DEPC treated deionized water, 5 ml of yeast tRNA 
(10 mg/ml) from SIGMA, 100 µl 50 mg/ml heparin (SIGMA), 250 µl 20% Tween-20, 
500 µl 10% CHAPS and 500 µl 0.5 M EDTA were added.  The above solution was 
filtered using 0.45 micron. 
2.2.7 Hybridization 
Immediately prior to hybridization 200 ng (or as per mentioned) of probe was 
added to 100 µl of prehybridization solution and heated at 95°C for 5 minutes.  This 
solution was then added to the embryos sitting in prehybridization solution. 
The reaction was placed at 65° C for overnight. 
2.2.8 Washes 
Hybridization solution was removed and the embryos were washed with 800 µl of 
prehybridization solution at 65°C for 5 minutes.  400 µl of 2X SSC solution was added 
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thrice to the existing solution at an interval of 10 minutes.  Solution was removed and 
embryos were washed twice for 30 minutes in 2X SSC (pH 7) at 65°C. 
Embryos were washed twice at room temperature for 10 minutes each in Maleic 
Acid Buffer (100 mM maleic acid, 150 mM NaCl, pH 7.5).  Next embryos were washed 
in Maleic Acid Buffer twice at 65°C for 30 minutes each.  Two washes were done in PBS 
at room temperature for 10 minutes each and then in PBT at room temperature for 5 
minutes.  All washes were carried out in a 24 well plate and agitated on a rocker. 
2.2.9 Pre blocking 
Embryos were placed in 1 ml of antibody buffer (10% goat serum heat 
inactivated, 1%Boehringer blocking reagent in PBT) at 4°C for overnight with rocking. 
2.2.10 Antibody 
Each embryo was placed in 1.5 ml of antibody buffer with 1:10,000 dilution of 
Anti digoxygenin antibody (1.5 µl) from Roche.  The reaction was incubated overnight at 
4°C with rocking. 
2.2.11 Washes 
Embryos were washed in 5 ml of PBT + 0.1% BSA, five times for 45 minutes 
each.  Next embryos were washed twice in PBT for 30 minutes each at room temperature. 
Embryos were further washed at room temperature twice in AP1 Buffer (pH 9.5) (100 
mMTris 9.5, 100 mM NaCl, 50 mM Magnesium chloride) for 10 minutes each with 
rocking. 
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2.2.12 NBT/BCIP 
For the process of color development to 20 ml NTMT (100 mM NaCl, 100 mM 
Tris at pH 9.5, 50 mM MgChloride, 1 mM levasmisol [0.48 g] and distilled water [84.5 
ml]) 90 µl NBT (Nitro-Blue Tetrazolium Chloride) and 70 µl BCIP (5-Bromo-4-Chloro-
3'-Indolyphosphate p-Toluidine Salt) was added. 5 ml of the above solution was added to 
each embryo including the experimental and negative controls.  Reaction was placed in 
dark and incubation time was very carefully monitored. 
2.2.13 Washes 
Reaction was stopped by washing the embryos thrice in 5 ml of PBS solution for 
5 minutes each. 
2.3 Construction of  Probe 
For the purpose of whole mount in situ hybridization four different types of 
probes were constructed: (i) 199 base pair DNA probe, (ii) 199 base pair RNA probe, (iii) 
665 base pair DNA probe and (iv) 665 base pair RNA probe. 
2.3.1 199 Base Pair Probe 
Total RNA was extracted from 3- 5 day old chick embryos using Ambion Totally 
RNA and was a generous gift from a fellow graduate student (Ricardo Leitao).  
Harvested embryos were weighed, flash frozen in liquid nitrogen and stored at -80°C 
until needed.  On the morning of RNA isolation twelve frozen embryos were rapidly 
transferred to a pool of liquid nitrogen in a pre chilled mortar and dry ice, and were 
ground to a fine powder using a mortar and pestle.  The powder was then placed in 
polypropylene tubes containing denaturing solution (a proprietary solution of guanidine 
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thiocyanate and EDTA) added in the ratio of 10 µl solution per milligram of tissue.  RNA 
extraction was done as per the manufacturer’s instructions.  
Step down RT PCR was performed using Qiagen’s one step RT PCR kit 
(Appendix B), using the following primers: 
Forward Primer                        3’ GCG AAG GAA GCT CGT AAC AT 5’ 
Reverse Primer                         3’GCT CGT GCA AAA ACA CAT TTG 5’ 
Step down / Touch down RT-PCR reaction was used as it increases the specificity 
and sensitivity of the RTPCR reaction.  Initial annealing temperature used was 65°C, 
with each cycle temperature was dropped by 0.5°C, making the final temperature to be 
50°C.  A total of 40 cycles were employed. 
Reverse Transcription     50°C for 30 minutes  
Initial PCR activation     95°C for 15 minutes  
3 step cycle: 
  Denaturation     94°C for 1 minute 
  Annealing     65°C for 1 minute 
  Extension     72°C for 1 minute 
        ---------------------- 
        30 cycles 
3 step cycle: 
  Denaturation     94°C for 1 minute 
  Annealing     50°C for 1 minute 
  Extension     72°C for 1 minute 
        ---------------------- 
        10 cycles 
Final extension      72°C for 10 minutes 
 
A 1X TAE 1% agarose gel was run to confirm the size of the amplified region. 
Band extraction was performed using Qiagen’s  MinElute Gel Extraction Kit as directed 
in the manufacturer’s protocol. 
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The amplified DNA was cloned in Promega’s pre-linearized pGEM- T Easy 
vector using T4 DNA ligase and reaction buffer as per the protocol (Appendix B).  The 
ligation product was transformed into JM 109 competent cells using Promega’s heat 
shock protocol.   Following the subsequent 90 minutes growth period, 100 µl of bacterial 
suspension was then spread onto pre-warmed LB agar plates containing ampicillin (100 
ug/ml), IPTG (80 µM) and XGAL (50 µg/ml) and the plates incubated overnight at 37°C. 
Five white colonies were selected and used to inoculate separate 5 ml cultures of LB 
media containing 100 µg/ml of ampicillin.  
A Zyppy Mini Prep Kit (Zymo Research) was next used to isolate plasmid from 
each culture (Appendix C), and the DNA was then quantified using a NanoDrop 
spectrophotometer and examined by agarose gel electrophoresis.  Plasmid DNA was sent 
out for sequencing to Sequetech Corporation (Mountain View) using M13 reverse and 
forward primers.  
BLAST analysis was performed using Tbx 5 sequence obtained from NCBI 
website w.r.t to the sequencing results in order to confirm the Tbx 5 insert identity.   
Multiple sequence alignment and local sequence alignment was then performed in 
order to find a region within the Tbx 5 gene of gallus gallus unique to this family member 
(since, as has been mentioned in the Introduction, significant sequence similarity is 
observed across the Tbx family).  Once a region unique to Tbx 5 was identified, primers 
targeting this region were designed using both Primer 3 (http://frodo.wi.mit.edu/primer3/) 
and software made available at the IDT Inc website. 
(http://www.idtdna.com/Home/Home.aspx 
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2.3.1.1 199 Base Pair DNA Probe 
For development of a DNA probe targeting the unique region of the Tbx 5 
transcript, secondary PCR was first performed using the Tbx 5 specific primers described 
above.  The PCR product was verified to be a single band using agarose gel 
electrophoresis, and the resulting DNA purified using Promega’s Wizard PCR clean up 
kit as per the manufacturer’s instructions (Appendix F).  The resulting DNA was DIG 
labeled using a Mirus’s Label IT kit as directed in the manufacturer’s instructions 
(Appendix I). 
2.3.1.2 199 Base Pair RNA Probe 
  For the creation of an anti-sense RNA probe, a secondary PCR reaction was first 
performed to create a transcription template using a pair of Tbx 5 gene specific primers, 
one of which was modified to bear an appended T7 promoter.  A similar approach was 
used to create a DNA template for production of a sense RNA probe.  The design of these 
primer pairs is shown below with the T7 promoter region underlined.  
For creation of a template able to support synthesis of sense RNA probe: 
Forward Primer: 5’ TAA TAC GAC TCA CTA TAG GGA GAT ACA ATG     
CAA GGA AGC G 3’ 
Reverse Primer: 5’ GTA AAA CGA CGG CCA GT 3’ 
Anti sense probe: 
 Forward Primer:  5’GCT CGT GCA AAA ACA CAT TTG 3’ 
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Reverse Primer:  5’ TAA TAC GAC TCA CTA TAG GGA GAG TTT ACA 
CAA AAA CGT GCT CG 3’ 
PCR product was analyzed using agarose gel electrophoresis and the product 
clean up carried out using Promega’s Wizard PCR Clean Up Kit (Appendix F).  For 
creation of the single stranded RNA probe in vitro transcription was performed using the 
Roche DIG labeling In Vitro Transcription kit containing Digoxygenin-11-UTP (Roche 
Inc) as per manufacturer’s instruction (Appendix G).  Resulting RNA was confirmed for 
size and yield by agarose gel electrophoresis.  
RNA was pelleted using Novagen’s Red Pellet Paint reagent according to the 
manufacturer’s instructions (Appendix H).  RNA was assayed for labeling efficiency by 
dot blotting followed by development with anti –DIG fragments conjugated to Alkaline 
Phosphatase and NBT/BCIP per the manufacturer’s instructions (Appendix J). 
2.3.2 665 Base Pair Probe 
         665 base pair DNA probe was prepared in collaboration with Dr. S. White and a 
fellow undergraduate student (Adreina Martinez).  Dr. White provided us with a 
pBluescript plasmid containing an insert of approximately 1400 bp, with about 800 bp of 
that being Tbx 5 cDNA. Liquid culture of LB/AMP (100 µg/ml) was prepared by 
inoculating the culture with the plasmid and incubating it overnight at 37°C with shaking. 
Plasmid prep was performed using Zyppy Plasmid Miniprep Kit (Appendix C).  DNA 
was quantified using a NanoDrop spectrophotometer.  In order to confirm for the 
presence of the Tbx 5 insert a double restriction digest was performed using EcoRI and 
NotI enzymes (Appendix D) and results were analyzed on a 1% agarose gel.  
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 The insert was cloned into Promega’s pre-linearized pGEM- T Easy vector and 
ligation was performed as per the manufacturer’s instructions (Appendix B).  The 
resulting ligation reaction mixture was then transformed into E. coli by a standard heat 
shock protocol, grown for 90 minutes and then plated onto LA/AMP/IPTG /XGAL plates 
and incubated overnight at 37°C.  Liquid culture was prepared by inoculating 5 ml of 
LA/AMP media with the bacterial suspension incubating overnight at 37°C with shaking. 
Plasmid Prep was performed using Zyppy Plasmid Mini Prep Kit (Appendix A). 
           The mini plasmid prep was sent out for sequencing using M13 reverse and forward 
primers.  The sequencing results were confirmed by performing a sequence alignment of 
Tbx 5 sequence obtained from NCBI web site.  
           Primer 3 was used to design the primers for Tbx 5 gene, GC% forward primer ((20 
base pair) was 55% and for reverse primer (20 base pair) was 55% and melting 
temperatures were 59.48 and 59.69 respectively.  The following primers were used 
Forward Primer:  3’ GCGAAGGAAGCTCGTAACAT 5’ 
Reverse Primer:   3’ GGAGGTAACAGCGATGAAGG 5’ 
       PCR reaction was set up using Qiagen Taq DNA polymerase and Core Buffer 
components (Appendix E).  PCR results were analyzed by running on a 2% agarose gel. 
The PCR product was cleaned up for the removal of any existing dNTP’s and salts  by 
using Promega’s Wizard SV gel and PCR Clean-Up System (Appendix F).  PCR clean up 
results were quantified using  spectrophotometer and confirmed by running an agarose 
gel. 
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 2.3.2.1  665 Base Pair DNA Probe 
 DNA was Digoxygenin labeled by using Label It Kit (Mirus Inc) as per the 
manufacturer’s instructions (Appendix H).  The kit covalently attaches Digoxin molecule 
to the nucleic acid.  Resulting Dig labeled DNA was analyzed by gel electrophoresis to 
confirm size and yield.  
          An assay was performed to check for the labeling efficiency using Dot Blot.  Dot 
blot was developed using anti-DIG Fab fragments conjugated to Alkaline Phosphatase 
and NBT/BCIP according to manufactures instructions (Appendix J). 
2.3.2.2 665 Base Pair RNA Probe 
  For RNA probes secondary PCR was performed using T7 ending Tbx 5 gene 
specific primers.  The following primer sequence was used to attach the T7 promoter 
(underlined region). 
Anti sense probe 
Forward Primer: 5’ GCG AAG GAA GCT CGT AAC AT 3’ 
Reverse Primer: 5’ TAA TAC GAC TCA CTA TAG GGA GAG GAG GTA 
ACA  GCG ATG AAG C 3’  
Sense probe 
 Forward Primer: 5’ TAA TAC GAC TCA CTA TAG GGA GAG CGAAGGAAG 
CTC GTAACA T  3’ 
 Reverse Primer:  5’ GGA GGT AAC AGC GAT GAA GG 3’ 
PCR product was verified using agarose gel electrophoresis.  PCR product clean 
up was done by using Promega’s Wizard PCR clean up kit (Appendix G). 
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For single stranded RNA probe in vitro transcription was performed using DIG 
labeling In Vitro Transcription kit containing Digoxygenin-11-UTP (Roche Inc) as per 
manufacturer’s instruction (Appendix H).  The resulting RNA was confirmed for size and 
yield by agarose gel electrophoresis.  
            RNA was pelleted using Novagen’s red pellet paint as per manufacturer’s 
instructions (Appendix I).  Pellet paint co-precipitant is a visible dye used in alcohol 
precipitation of the nucleic acid. DNA/RNA is efficiently precipitated and easily located 
by the pink color of the dye. 
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3- RESULTS 
3.1 Total RNA Isolation 
Total chick embryo’s RNA isolated using Ambion’s totally RNA was diluted 1:2 
and analyzed on nanodrop for concentration (Fig. 8). 
 
 
 
Fig. 8. Nanodrop results of total RNA isolated diluted 1:2. 
 
Agarose gel electrophoresis of the sample confirmed the RNA was intact (gel 
results not shown), and the total RNA was then used for RT-PCR as described below. 
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3.2 RT-PCR RESULTS 
 In order to create 199 bp DNA and RNA probe, RT-PCR was performed on total 
RNA extracted from chick embryos.  A 1% agarose gel was run to check for the RT-PCR 
product (Fig. 9).  The agarose gel results confirm the presence of about 200 bp long 
desired amplified DNA. 
 
 
Fig. 9. 1% agarose E gel to confirm the 199 base pair amplified region by RT-PCR. Lane 
1: 100 bp DNA ladder, Lane 2, 3: RT-PCR product. 
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3.3 Probe Construction  
During the construction of our probe we performed Multiple Sequence Alignment 
for some members of Tbx family and found them to be very similar suggesting homology 
(Fig. 10).  The asterisk sign represents the identical bases among Tbx 2, 3, 4, 5, and 20. 
Multiple sequence alignment results below show significant sequence similarity among 
the Tbx family members.  It is also interesting to note that at many base positions 3 or 4 
bases are identical.  Thus it is essential to identify region of Tbx 5 which doesn’t share 
significant sequence similarity with other family members in order for the probe to be 
Tbx 5 specific rather than Tbx family specific. 
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Fig. 10. Results of Multiple Sequence Alignment of Tbx 2, Tbx 3, Tbx 4, Tbx 5 and Tbx 
20 showing sequence similarity among the Tbx family members. 
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Since we wanted our probe to be specific to Tbx 5 and not target other members 
of the Tbx family, we designed our probe by identifying regions of Tbx 5 sequence which 
depicted least similarity to other members of the Tbx family.  That area of least similarity 
(Fig. 11) is highly unlikely to cross hybridize with other Tbx family members and give 
false signal for Tbx 5.  This region was used to design the probe using Primer 3 and free 
software available at IDT website. 
 
 Fig.11. Depiction of unconserved region of Tbx 5 used to create the probe. Yellow 
highlighted region of Tbx 5 depicts poorly conserved region amongst the Tbx family 
members and was used for designing probe specific to Tbx 5.  
 
3.4 Sequencing Results 
A 1% agarose gel electrophoresis confirmed the RT-PCR product was of the 
expected length of about 200 bp.  After the RT-PCR product was purified, it was ligated 
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in pGEM –T Easy vector.  The following are the sequencing results (Fig. 12).  The blue 
colored area indicates the 3’ readable part of the T 7 Promoter.  Red colored area 
indicates the target 199 base pair region.  Underlined red area indicates forward and 
reverse primers used to amplify the region. 
 
 Fig.12.  Sequencing results of pGEM T Easy vector containing 199 base pair Tbx 5 
region. 
 
In order to double check if the 199 base pair amplified region belonged to Tbx 5 
of chicken, a BLAST search was performed against the NCBI database.  The results (Fig. 
13) shown below depict 100% sequence identity, thus suitable as a probe for in situ 
hybridization. 
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Fig.13. BLAST results confirming the identity of 199 base pair long probe. 
Below are the sequencing results of pGEM –T Easy vector containing the 665 bp 
Tbx 5 probe (Fig. 14), the blue colored area indicates the 3’readable part of the T7 
promoter.  The red colored area indicates the desired 665 bp Tbx 5 region.  The red 
underline region denotes the forward and the reverse primers used to amplify the region. 
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Fig.14. Sequencing results of pGEM- T Easy vector containing 665 bp Tbx 5 region. Blue 
region indicates T7 Promoter, green region indicates the beginning of pGEM-T Easy 
vector, red area indicates the desired probe region and the underlined red colored area 
indicates the primers used to amplify the probe. 
 
 The pGEM- T Easy plasmid sequence containing 665 bp Tbx 5 region was 
compared with chicken Tbx 5 mRNA retrieved from NCBI website using a BLAST 
search (Fig. 15).  The results show that the two sequences are identical in overlapping 
regions i.e., 100% similarity indicating it to be suitable as a probe for in situ 
hybridization.
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Fig.15. BLAST results confirming the 665 bp probe identity to be identical to Tbx 5. 
  
 
 
3.5 Results of PCR 
 
 After the confirmation of the sequence identity, PCR amplification was done with 
Tbx 5 specific primers (Fig.16).  In order to trouble shoot for our low yield during in vitro 
transcription we designed PCR primers with 5’ overhang of T7 promoter. 
  48  
       
    Fig. 16 (A)              Fig. 16 (B) 
 
Fig. 16 (A). Results of PCR product for 199 bp probe. Fig. 16 (B).Results of PCR 
amplification for 665 bp probe. 
 
3.6 Double Restriction Digest Results 
 A pBluescript vector containing 1400 bp long Tbx 5 insert was supplied by Dr. 
White.  We performed a double digest on the vector using Not1 and EcoR1 enzymes. 
Results of the double enzyme digest were analyzed on a 1% agarose gel (Fig.17).  
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Fig.17. Results of double restriction digest of plasmid pBluescript containing Tbx 5 
insert. Lane 1: Promega’s1 Kb DNA ladder, Lane 2: uncut pBluescript vector containing 
Tbx 5 insert. Lane 3: a mixture of uncut, linearized and nicked pBluescript vector 
containing Tbx 5 insert following incubation with Not1.  Lane 4: a mixture of nicked and 
linearized pBluescript vector containing Tbx 5 insert following incubation with EcoR1. 
Lane 5: Not1 and EcoR1 double digest showing empty, linearized  pBluescript vector and 
free Tbx 5 insert. 
 
 For our purpose lane 3 and 4 are irrelevant (Lane 3 shows three bands indicating 
incomplete digestion by enzyme NotI which might be due to the shelf life of the enzyme. 
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The upper band represents uncut DNA, second band indicates potentially linearized DNA 
and the third band is the nicked DNA).  The Not1/EcoRI double digest in lane 5 shows 
two bands, one around the size of 3000 bp and other around the size of 1400 bp.  The 
upper band indicates the empty pBluescript vector and the lower band indicates the 1400 
bp Tbx 5 insert. 
 
 
3.7 Results of Dig Labeling Efficiency 
We performed a Dig Labeling efficiency dot blot assay to confirm the 
digoxygenin labeling on a nylon membrane. 1:10 dilution series was plotted on the nylon 
membrane starting with 6.95 ng of DNA.  We found out that we were able to detect down 
to a concentration of 6.95 pg of probe DNA (Fig. 18). 
 
Fig.18. Results of Dot Blot Assay to check for the labeling efficiency. (A): 6.95 ng of 
DNA, (B): 0.695 ng of DNA, (C): 0.695 pg of DNA, (D): 6.95 pg of DNA, (E) : >6.95 pg 
of DNA, (F): >6.95 pg of DNA, (G) > 6.95 pg of DNA and (H) TE. 
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3.8 In Vitro Transcription  Results    
 To generate anti-sense riboprobes, we first created T7-ended 665 and 199 base 
pair Tbx 5 templates by appending a T7 promoter to the reverse primers.  Following PCR 
amplification with these modified primers we were able to isolate templates suitable for 
the generation of 199 and 665 base long anti- sense RNAs.  Each template was then used 
in an in vitro transcription reaction employing DIG-labeled UTP, allowing the production 
of DIG- labeled antisense RNA for use in the in situ hybridization experiments.   
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Fig.  19.  Results of 2% agarose gel electrophoresis to confirm the size of Dig labeled 
DNA and RNA probes. Lane 1: Dig labeled 199 bp DNA probe. Lane 2: 100 bp 
Invitrogen DNA ladder. Lane 3: 199 bp Dig labeled RNA sense probe and Lane 4: 199 
bp Dig labeled RNA anti sense probe. Lane 5: 665 bp Dig labeled RNA sense probe. 
Lane 6: 665 bp Dig labeled RNA anti sense probe, Lane 7: 100 bp Invitrogen DNA 
ladder and Lane 8: 665 bp Dig labeled DNA probe. 
 
3.7 Whole Mount In Situ Hybridization Results 
 Whole mount in situ hybridization using Tbx 5 specific probes was performed 
using the techniques described in the Methods sections.   No hybridization was observed 
in the control tissue with no probe (Fig. 20) and the control tissue probed with sense 
RNA (Fig. 21).   Distinct and definitive signal was observed in the experimental tissues 
probed with Tbx 5 specific probes (Fig. 22 – Fig.  33).   
        
                                             
Fig. 20 (A) & (B). Negative experimental control with no probe for whole mount in situ 
hybrdization for Tbx 5.  (A). Experimental Control  (No probe).   (B). Magnified portion 
of Fig. 20 (A) Control (No probe).   
 
 As shown in Fig. 20, the chick embryo is at developmental stage HH 22-23 and is 
experimental control with no probe.   Lack of any signal denotes no hybridization.   
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Fig. 21 (A). Negative control (Sense probe at 200 ng/ml) for whole mount in situ 
hybridization. Fig.21 (B) is a magnified version of negative control, sense probe. 
 
                Fig.  21 exhibits chick embryo at developmental stage HH 22-23.   It is 
negative experimental control, probed with Tbx 5 sense probe.   It shows no signal 
depicting lack of non specific binding and background. Lack of signal in the control 
tissue also denotes the specificity of the anti-DIG antibody. 
        
Fig. 22. Whole mount in situ hybridization of chick embryo using 199 bp RNA probe for 
Tbx 5 at  200 ng/ml.  (A). RNA 199 bp probe (antisense probe at 200 ng/ml).  (B). 
Magnified portion of Fig. 22 (A). 
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 Fig. 22 (A) is stage HH 23-25 embryo probed with Tbx 5 at  200 ng /ml, signal 
can be seen in atrioventricular canal and left ventricle.  Fig. 22 (B) is a magnified version 
of Fig. 22 (A). 
                            
Fig. 23. Whole mount in situ hybridization of chick embryo using 199 bp RNA probe for 
Tbx 5 at 750 ng/ml.  (A). RNA 199 bp probe (antisense probe at 750 ng/ml.  (B). 
Magnified portion of Fig. 23 (A). 
 As shown in Fig. 23 (A), chick embryo is at developmental stage HH 24 and is 
probed at 750 ng /ml.  In the chick embryo strong signal can be seen in the atria, 
atrioventricular canal, the left ventricle, the retinal region, and the forelimb buds.   
                                
                      
Fig. 24. Whole mount in situ hybridization of chick embryo using 199 bp RNA probe for 
Tbx 5 at 1000 ng/ml.  Fig. 24 (A). RNA 199 bp probe  (antisense probe at 1000 ng/ml)     
(B). Magnified portion of Fig. 24 (A) (antisense probe at 1000 ng/ml).                          
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Fig. 24 (A) is HH 24-25 staged chick embryo probed with Tbx 5 at 1000 ng/ml.   
Definitive signal can be seen in the atria, the ventricle, retinal regions of the eye, and the 
developing forelimb buds.  Note the outflow tract of the embryo is ripped. Fig. 24 (B) is a 
magnified version of Fig. 24 (A).    
                           
Fig. 25. Whole mount in situ hybridization of chick embryos with Tbx 5 665 bp RNA 
probe at 200 ng/ml.  RNA 665 bp probe (antisense probe at 200 ng/ml.   (B). Magnified 
portion of Fig. 25 (A).   
 
 As shown in Fig. 25, chick embryo is at developmental stage HH 19-20 exhibiting 
signal in atria, atrioventricular canal, the left ventricle, forelimb buds, and the retina. 
     
Fig. 26. Whole mount in situ hybridization of chick embryos with Tbx 5 665 bp 
RNAprobe at 750 ng/ml.  (A). RNA 665 bp probe (antisense probe at 750 ng/ml).    
(B). Magnified portion of Fig. 26 (A). 
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 Fig. 26 depicts a chick embryo at developmental stage HH 25-26, where signal 
can be seen in the atria and the apex of the left ventricle along with strong Tbx 5 
expression in the forelimb buds and the retina.    
                                               
Fig. 27. Whole mount in situ hybridization of chick embryos with Tbx 5 665 bp RNA 
probe at 1000 ng/ml.  Fig. 27 (A). RNA 665 bp probe (antisense probe at 1000 ng/ml)   
(B). Magnified portion of Fig. 27 (A) (antisense probe at 1000 ng/ml).   
                       
  In Fig. 27, embryo is at the developmental stage HH 18-19.   Clear signal can be 
seen in the atrial region of the heart along with the retinal region and the developing 
forelimb buds.    
                         
Fig. 28. Whole mount in situ hybridization of chick embryos probed with 199 bp DNA 
probe at 200 ng/ml.  Fig. 28 (A). DNA 199 bp probe (Probe at 200 ng/ml).  (Probe at 200 
ng/ml) (Probe at 200 ng/ml).                    
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Fig. 29. Chick embryos probed with 199 bp DNA probe at 750 ng/ml for whole mount in 
situ hybridization of Tbx 5.  Fig. 29 (A). DNA 199 bp probe (Probe at 750 ng/ml).  (B). 
Magnified portion of Fig. 29 (A) (Probe at 750 ng/ml).   
 
    
Fig. 30. Whole mount in situ hybridization of chick embryos using 665 bp DNA probe 
for Tbx 5 at 200 ng/ml.  Fig. 30 (A). DNA 665 bp probe  (antisense probe at 200 ng/ml)      
(B). Magnified portion of Fig. 30 (A) (antisense probe at 200 ng/ml).   
  
 As shown in Fig. 30, chick embryos at stage HH 21-22 exhibit staining in the 
ventricular region of the heart, along with strong staining in the forelimbs and relatively 
weaker staining in the retina.  It is to be noted that the outflow tract is broken. 
 
  58  
    
Fig. 31: Whole mount in situ hybridization of chick embryos probed with Tbx 5  665 bp 
DNA probe at 750 ng/ml.  Fig. 31 (A). DNA 665 bp probe (antisense probe at 750 
ng/ml).  (B). Magnified portion of Fig. 31 (A) (antisense probe at 750 ng/ml).   
 
 As shown in Fig. 31, chick embryo is at stage HH 20-21.  Chick embryo 
exhibits no staining in the outflow tract, but signal can be seen in the left atria, left 
ventricle and the atrioventricular region.  Also strong signal is seen in the forelimb buds 
and the retina of the eye.  
 
    
                       
                     Fig. 32.  Chick embryos probed with Tbx 5 665 bp DNA probe at 1000 
ng/ml whole mount in situ hybridization. Fig.32 (A). DNA 665 bp probe (antisense probe 
at 1000 ng/ml).  (B). Magnified portion of Fig. 32 (A) (antisense probe at 1000 ng/ml).                       
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Fig. 33. Images of embryo stored in methanol for a month and probed with 199 bp 
DNA  at  750 ng/ml. Fig. 33 (A). Embryo stored in methanol for a month (DNA 
199 bp probe at 750 ng/ml).  (B). Magnified portion of Fig. 33(A) (DNA 199 bp 
probe at 750 ng/ml). 
                     .                        
 
As shown in Fig. 33, the chick embryo is at the developmental stage HH 
23-24.   The embryo has been stored in methanol for a month.   Hardening of the 
tissue has been observed in embryos stored in methanol for a month.  Signal can 
be seen in the atrial region of the heart, retinal region of the eye, and the 
developing forelimb buds. 
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4- DISCUSSION 
Tbx family members are transcription factors defined by the presence of a highly 
conserved sequence called the T-domain, involved in DNA binding and protein 
dimerization (Minguillon et al., 2003).  While a number of Tbx gene family members are 
known to play some role in cardiogenesis, Tbx 5 has captured the greatest interest.  This 
is probably due in large part to the discovery that mutations in Tbx 5 are associated with 
the congenital heart defect known as HOS (Holt Oram Syndrome, OMIM 142900), 
characterized by upper limb and heart defects, the latter specifically associated with 
conduction and septal defects in the heart (Basson et al., 1999). 
Tbx 5 is essential for heart and forelimb formation in all vertebrates, but its 
regulation and functional interactions with other transcription factors and structural 
proteins are still not completely understood.  
Careful analysis of our results indicates that Tbx 5 is expressed in the eye, 
forelimb, atria, atrioventricular canal, and left ventricle.  Our results are in agreement 
with the findings of Takeuchi et al. (2003), who also report Tbx 5 expression in the dorsal 
side of the chick’s developing eye.  According to those investigators, expression of Tbx 5, 
in the chick eye is first seen around stage HH 11 in the retina and then found later in the 
dorsal eye cup, retinal pigment epithelium, and neural retina.  Bruneau et al. (1999) 
conducted whole mount in situ hybridizations on mouse embryos to study the role of Tbx 
5 in early heart development.  While their results are in agreement with ours with respect 
to Tbx 5 expression in the heart, our findings differ regarding the extent of retinal 
staining.   To better illustrate this point we present the two results below for direct 
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comparison.  Fig. 34 (taken, with permission, directly from the Bruneau paper) displays 
only very light staining in the eye compared to that seen in our study (Fig. 35).  A number 
of possible interpretations might follow from these results.  One is that the chick eye 
merely has more pigmentation, and all the “signal” was really due to this endogenous 
pigment. Unstained chick embryos or those stained with “sense” riboprobes as a negative 
control do not show this degree of signal, so differences in endogenous eye pigmentation 
do not appear to offer a sufficient explanation.   An alternative interpretation is that the 
differences in retinal staining intensity in one study or the other are simply artifactual.  
Perhaps, for example, if Bruneau and co-workers had repeated their study, they might 
have indeed observed greater retinal expression of Tbx 5.   Conversely, we might see less 
upon repeated re-examination of our own.  We have reproduced these results a number of 
times, however, so we are inclined to believe our results are true.  A more provocative 
interpretation is that there might indeed be real expression differences between the two 
species used in these studies (mouse vs. chick).  The two embryos shown in Figures 34 
and 35 are approximately of the same developmental stage, so a simple explanation based 
on stage differences does not seem reasonable.  It may instead be that there exist real 
differences in the pattern and extent of Tbx 5 retinal expression in avians compared to 
mammals.  The keen visual acuity (resolution) of avians (especially well studied in 
hawks, owls, eagles, and other birds of prey) is one obvious physical manifestion of a 
difference in the eyes of these two species.  It seems entirely possible that the difference 
in Tbx 5 expression we observe is genuine, reflecting a subtle but real alteration in the 
genetic and developmental program utilized in the embryonic construction of the retina.   
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Fig. 34. In situ hybridization to Tbx 5 transcripts in mouse embryos, exhibiting strong 
staining in the heart and developing upper limb but low expression of Tbx 5 in the eye. 
Figure reprinted from Bruneau et al. with permission from Elsevier. 
 
 
Fig. 35. Whole mount in situ hybridization to Tbx 5 transcripts in chick embryos, 
indicating significant expression in the eye, heart and developing upper limb.  
 
Interestingly, conflicting data have been published regarding the ventricular 
expression domains of Tbx 5.  According to Bruneau et al. (1999) and Takeuchi et al. 
(2003), Tbx 5 is expressed only in the left ventricle and not in the right ventricle.  Bimber 
et al. (2007), however, report the expression of Tbx 5 in both the right and left ventricles 
(Fig. 36).  They performed immunohistochemical studies on embryonic chick heart, 
finding strong expression of Tbx 5 in the left ventricle and atria and low expression in the 
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right ventricle.  Results of our studies are in agreement with Bruneau et al. (1999) and 
Takeuchi et al. (2003) and apparently at odds with those of Bimber et al (2007), as we 
report expression of Tbx 5 in the atria and the left ventricle with no detectable signal in 
the right ventricle. 
     
 
Fig. 36. Results of immunohistochemical studies conducted to study the expression of 
Tbx 5 in chick embryo heart. Figure has been modified to show the results of only Tbx 5 
from Bimber et al. with permission from Elsevier.  
 
   
 While not commented upon in the papers cited above, however, these 
discrepancies may actually reflect differences in what is being detected.  The right 
ventricular expression of Tbx 5 reported by Bimber et al. (2007) might be explained by 
the fact that Bimber et al. (2007) performed immunohistochemical studies which target 
the TBX 5 protein rather than Tbx 5 mRNA.  Since a number of labs have reported the 
expression of Tbx 5 mRNA throughout the entire heart tube at very early stages of 
cardiac development (Bruneau et al., 1999; Krause et l., 2004), it may be that the TBX 5 
protein is itself quite stable, and able to be maintained in the right ventricle long after the 
Tbx 5 gene has ceased making transcript.  It is thus possible that the apparent discordance 
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between our work and that of Bimber is illusionary.  Transcription off the Tbx 5 gene in 
the right ventricle could indeed be fully repressed at later stages of development (when 
we probe for it), but the earlier expression could give rise to a stable protein that is still 
detectable via immunohistochemistry.     
Whole mount in situ hybridization is a complex technique exhibiting its own 
constellation of irksome (and sometimes unique) problems like sensitivity to degradation 
by RNases.  The sequence of interest in any particular tissue, for example, might be 
present but in very low abundance, or might remain bound up with protein making 
hybridization with a complementary probe extremely improbable (if not, for all practical 
purposes, impossible).  Tissue permeability, and thus target accessibility, represents 
another technically difficult problem to overcome.  It is extremely important to increase 
the permeability of the tissue without destroying the morphological integrity of the tissue.   
Detergents or proteases can both be used, but both can literally disintegrate the embryo if 
used at too high a concentration for too long.  The size of the probe is also an important 
parameter to consider.  Choice of type of probe, its labeling conditions, stringency of the 
washes and determining the temperature of washes with or without shaking while 
maintaining the structural integrity of the extremely fragile embryo present a challenge in 
the successful functioning of the technique. 
 One of the most common problems encountered with in situ hybridization studies 
is the unwanted background staining.  It is very difficult to diagnose the exact cause of 
background staining.  Probe and/or alkaline phosphates antibody conjugate can also be 
trapped by the internal cavities of the tissue like the brain, heart and eyes.  During the 
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course of this study we were able to significantly reduce the background staining by 
opening the brain cavity by punching a hole in one or more regions of the forebrain, 
midbrain or the telecephalic hemisphere. 
It is essential to be very careful during the process of embryo harvest, as the 
embryo is extremely delicate and tightly bound by protective membranes.  Careful and 
complete removal of these adherent membranes is crucial to in situ hybridization studies 
as these membranes inhibit the penetration of fixative, dehydrating solutions and the 
probe.  
After the harvest the embryos are supposed to be fixed immediately.  Fixation is 
the first and a very crucial step for any hybridization protocol.  It not only keeps the 
tissue/ cell intact but also prevents degradation of intracellular nucleic acid.  4% PFA 
(paraformaldehyde) is the most common and widely used fixative agent for any in situ 
hybridization protocol.  In order to fix the embryos, we initially used 4% PFA which was 
prepared and chilled a day in advance of the harvest.  Our experience during the course of 
this study yielded much better results with 4% PFA prepared and chilled an hour before 
starting the harvest.  It is essential to be very careful to prepare all the reagents in RNase 
free water.  
We performed 8 sets of whole mount in situ hybridization experiments where we 
tried to optimize our protocols in order to significantly reduce the background signal 
observed in the initial results.  We studied, for example, the effects of storing the 
embryos up to a month in methanol after fixation as compared to just moving to the next 
step of rehydrating the embryos. We concluded that using the freshly fixed embryos 
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which were dehydrated and then rehydrated in one step yielded better results than storing 
them in 100% methanol as we observed hardening of the tissue in embryos which were 
stored in methanol (Fig. 33).  Hardening of the tissue means that the proteins coagulate 
which further makes tissue permeability more difficult.  This observation might be 
because methanol is used as a fixative and acts as a protein denaturizing agent.  
Optimization studies were performed on the duration of proteinase K digestion. 
Duration of proteinase K digestion is a critical step as insufficient digestion would lead to 
low hybridization signal and over-digestion might destroy the tissue morphology.  We 
compared the effect of performing proteinase K digestion for 15 minutes with respect to 
digestion for 30 minutes (data not shown).  Better hybridization signal with 30 minutes 
digestion was observed.  Secondary fixation consisting of 4% paraformaldehyde and 
0.2% gluteraldehyde for 15 minutes yielded better results as compared to no secondary 
fixation. 
We also optimized the stringency wash by decreasing salt concentration to wash 
off the non-specifically bound probe.  During the course of this study we experimented 
with a number of hybridization temperatures such as 55°C, 60°C, 62°C and 65°C.  We 
concluded that the higher hybridization temperature of 65°C yielded the best results 
without destroying or altering the structural integrity of the tissue. 
Many Tbx 5 hybridization studies have been conducted over the past decade, but 
almost none of these studies have published any significant information regarding their 
probe sequence, let alone the specific conditions used in their hybridization protocol.  
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Wilson et al. (2002) states, “Specific residues within the T-box are 100% 
conserved in all members of the family.”  
Also the expression domain of various Tbx family members in the heart remains 
controversial.  According to Yamada et al. (2000), the transcripts of Tbx 2, Tbx 3 and Tbx 
5 were expressed in an overlapping fashion in early crescent formation, indicating a high 
degree of sequence conservation amongst the Tbx family.  This leads to serious doubts 
regarding the specificity of the probe.  Whether the probe hybridizes to Tbx 5 specifically 
or cross hybridizes to Tbx family members due to sequence conservation still needs to be 
determined.  Bioinformatics tools like BLAST and Multiple Sequence Alignment (Fig. 
10 and 11) were employed in this study to find an area of Tbx 5 with minimum sequence 
conservation with other Tbx family members to ensure the specificity of the probe to Tbx 
5. 
During the course of the 199 base pair probe construction, we performed the Blue/ 
White screening using LA/AMP/IPTG/X-Gal plates to check for ligation.  Along with 
white and blue colonies we also found some light blue colonies which after a week of 
incubation slowly turned dark blue.  Along with the white colonies, we also sent out these 
light blue colonies for DNA sequencing. It was interesting to note that the light blue 
colonies contained the insert.  It might be possible that the insert doesn’t contain a STOP 
codon in frame with the lac Z gene, thus leading to a fusion protein which is functional as 
the alpha peptide of Lac Z (Murray et al., 1993).  Probe length of less than 500 bp (199 
bp in our case) might be maintained in lac Z’s reading frame, leading to the formation of 
light blue colonies. 
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 We had to troubleshoot the in vitro transcription reaction to work efficiently.  
Our initial attempts at in vitro transcription produced a low yield, which might be 
because our sequence of interest (Tbx 5) was somehow forming a secondary structure in 
the context of the plasmid which prevents efficient transcription.  To circumvent this 
transcriptional inefficiency we designed new primers with the T7 promoter on the reverse 
primer followed by the desired region of the Tbx 5 gene for the creation of the antisense 
probe (Fig. 37) and performed the PCR reaction.  After cleaning up the PCR product we 
performed the in vitro transcription and got the desired results.   
 
(A). Structure of linear template of the plasmid containing the TBX 5 insert. 
   
    . 
(B). Structure of the PCR amplified region for the creation of antisense RNA probe. 
     
(C). Structure of the PCR amplified region for the creation of sense RNA probe. 
 
Fig. 37. Depiction of primer design having T7 promoter at the end of the amplified 
region, for the successful creation of antisense by in vitro transcription. The arrows 
indicate the forward and the reverse primer used. 
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 One important aspect of this project was to compare the efficiency of the DNA 
probe vs. the RNA probe.  For the riboprobe, in theory the bonding between the RNA 
probe and the mRNA present in the tissue should be more thermostable than a DNA: 
RNA hybrid, potentially giving rise to a stronger signal by minimizing disassociation of 
target:probe duplexes.  Certainly a RNA: RNA hybrid would be more resistant to 
digestion by many common cellular RNases than either a free transcript or RNA probe, 
but this would also be true for a DNA: RNA duplex as well.  During hybridization there 
is no competition between the sense and antisense, as only antisense is available for the 
riboprobe to hybridize with the target mRNA so the RNA probe should be more efficient. 
Unexpectedly, we did not find much difference between the specificity or the signal 
intensity between the RNA and the DNA probe.  Our findings were in agreement with the 
findings of Forghani et al. (1999).  In our experience the DNA probes are much more 
stable and are also more cost and time efficient thus proving to be a viable alternative to 
RNA probes. 
We also compared probing the tissue with three different concentrations of 200 
ng/ml, 750 ng/ml and 1000 ng/ml for both the DNA probe and the RNA probe and did 
not find any significant difference in the results.  So in principle it is a good idea to back 
off to lowest concentration, i.e., a concentration of 200 ng/ml in order to minimize 
background staining, non specific binding and be cost efficient. 
Probe length is an important parameter to consider during in situ hybridization.  A 
probe length of 200-1000 bp is considered optimum.  Previous work done in Dr. White’s 
laboratory using a 1000 bp probe yielded background signal, so we decide to use two 
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different probes of 199 bp and 665 bp length.  Consider a 665 bp probe, its molecular 
weight would be 665 * 660/2 daltons = 219450 daltons, which in itself is a huge molecule 
to penetrate the tissue.  We compared two different probes of length 199 bp and 665 bp. 
Shorter probe length allows easier probe penetration but carries less of chemical label 
(digoxygenin in our case) whereas larger probe length carries more digoxygenin so 
should lead to stronger signal strength with potentially less able to penetrate the tissue 
and/ or more likely to be trapped.  Relative to the small number of experimental results 
that we have, we found the signal in the heart to be a little lighter in case of the 665 bp 
probe.  
In situ hybridization is very technique dependent where altering conditions like 
fixation, proteinase K digestion, stringency washes, and hybridization temperature has   
resulting effects which may have tremendous consequences on the results.  In situ 
hybridization targets the mRNA present in the tissue.  The mRNA molecule is only made 
when the gene for that particular protein is turned on and expressed, so in situ 
hybridization is dependent on the developmental stage of the embryo.  Tbx 5 is known to 
be up/ down regulated in different parts of the chick embryo at various stages of 
development.  
One future direction for the laboratory might be to perform microarray 
experiments on RNA isolated from different regions of the heart at different stages of 
development, but is limited by the lack of chick arrays containing large number of genes. 
Another alternative might be to perform microsurgery in conjunction with RT-PCR 
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experiments under different growth conditions to reveal when and to what extent a 
specific gene is switched on. 
With respect to in situ hybridization, we would highly suggest that more 
experiments be conducted to examine the effect of probe length on the signal strength.  In 
spite of the amount of work done in this project, more work needs to be done to create a 
much more detailed developmental atlas for a better understanding of Tbx 5 expression in 
chick organogenesis. 
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Appendix A 
Protocol for Step Down RT-PCR 
Step Down RT-PCR was performed using Qiagen’s One Step RT-PCR kit.  The 25 µL 
reaction was assembled on ice as follows 
          Rxn volume 
 
RNase free water        16.84 µL  
5XQiagen One Step RT-PCR buffer      5µL 
dNTP mix         1 µL 
Tbx 5 199 base pair forward primer (0.6 µM)     
1.5 µL 
Tbx 5 199 base pair reverse primer (0.6 µM)                1.5 µL 
Qiagen One Step RT-PCR enzyme mix       1 µL 
RNA at 3137.2 ng/µL        0.16 µL 
                                                                                                                      ------------------- 
                                                                                                                        25 µL 
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Appendix B 
Protocol for Promega’s  pGEM- T Easy Vector System 
The transformation reaction was performed using Promega’s  pGEM- T Easy Vector 
System.  3:1 insert: vector molar ratio was used (10 ng of insert DNA). The reaction was 
assembled as per follows: 
 
- pGEM-T Easy vector tube was briefly centrifuged. 
- Vortex the 2X ligation reaction and set the reaction as follows 
Ligation Reaction: 
 Standard Reaction Positive Control Background 
2X Rapid Ligation 
Buffer 
5 µL 5 µL 5 µL 
pGEM-T Easy 
Vector 
1 µL 1 µL 1 µL 
PCR Product 1 µL X X 
Control Insert DNA X 2 µL X 
T4 DNA Ligase 1 µL 1 µL 1 µL 
Deionized Water 2 µL 1 µL 3 µL 
Total Reaction 
Volume 
10 µL 10 µL 10 µL 
 
 
- Mix the reaction by pipetting and incubate the reaction at room temperature 
for 1 hour. 
 
Transformation Reaction 
Transformation was performed using highly competent JM 109 cells. 2 
LA/AMP/IPTG/XGal plates were used for each ligation reaction. 
  80  
- 2 µL of ligation reaction was placed in a sterile tube on ice. 50 µL of JM109 
competent cells were added to the tube. The tube was gently flicked and 
placed on ice for 20 minutes. 
- The tubes were heat shocked for 45 seconds in a water bath at 42°C. 
- Tubes were immediately placed on ice for 2 minutes. 
- 950 µL of SOC medium was added to the tube. 
- Reaction was incubated for 1.5 hours at 37°C with shaking. 
- 150 µL of reaction was plated using aseptic techniques on 
LA/AMP/IPTG/XGal plate. 
- The plates were placed in the incubator at 37°C for overnight. 
 
 
Vector map of Promega’s pGEM-T Easy Vector from 
http://www.promega.com/figures/popup.asp?fn=1473va 
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Appendix C 
Protocols for Zyppy MiniPrep Kit 
 Add 600 µl of bacterial culture grown in LB media in a sterile 1.5 ml 
centrifuge tube and centrifuge at max speed for 30 seconds.  Discard the 
supernatant and repeat the steps if necessary for a maximum of 3 ml of 
liquid culture.  Dissolve the bacterial pellet completely in 600 µl of TE or 
water. 
 Add 100 µl of 7X lysis blue to the centrifuge tube and mix by inverting 4-
6 times.  Change of color from opaque to clear blue indicates complete 
lysis.  Care should be taken to proceed to the next step within 2 minutes. 
 Add 350 µl of cold neutralization buffer and mix thoroughly by inverting 
the   tube. On completion of neutralization the solution turns yellow and 
yellow precipitate is formed. 
 Centrifuge at 11,000 -16,000 * g for 2-4 minutes. 
 Transfer the supernatant to the Zymo Spin IIN column provided without 
disturbing the pellet. 
 Place the column into Collection Tube and centrifuge for 15 seconds. 
 Discard the flow through and place the column in the same Collection 
Tube. 
 Add 200 µl of Endo Wash Buffer to the column and centrifuge for 15 
seconds. Discard the flow through. 
 Add 400 µl of Zyppy Wash Buffer to the column and centrifuge for 30 
seconds. 
 Transfer the column to a sterile 1.5ml micro centrifuge tube and add 60 µl 
of Zyppy Elution Buffer to the center of the column matrix and let stand 
for 1 minute at room temperature. 
 Centrifuge at max speed for 15 seconds to elute the plasmid DNA. 
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Appendix  D 
Protocol for Double Restriction Digest 
 
 
 uncut Single Cut 
(NotI) 
Single Cut 
(EcoRI) 
Double Cut 
(NotI, EcoRI) 
10 X RE Digest 
Buffer H 
2 µl 2 µl 2 µl 2 µl 
TBX 5  Plasmid 1 µl 1 µl 1 µl 1 µl 
NotI (10 U/ µl) X 1 µl X 1 µl 
EcoRI (10 U/ 
µl) 
X X 1 µl 1 µl 
Deionized 
Water 
16.8 µl 15.8 µl 15.8 µl 14.8 µl 
Acetylated 
BSA 
0.2 µl 0.2 µl 0.2 µl 0.2 µl 
 
 
Both NotI and EcoRI enzymes were from Promega.  The reaction was assembled on ice. 
Reaction was incubated at 37°C overnight in water bath for complete digest. 
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Appendix  E 
Protocol for Qiagen’s Taq DNA Polymerase PCR 
 Thaw 10X PCR buffer, dNTP mix, primer solutions, DNA and keep it on ice. 
 Prepare a master mix as follows except the template DNA 
 
Reagents Volume 
Deionized water 38.75 µl 
dNTP mix 1 µl 
Forward Primer 2.5 µl 
Reverse Primer 2.5 µl 
Template at 19.3 ng/ µl 1 µl 
Taq DNA polymerase 0.25 µl 
10 X PCR Buffer 5 µl 
Total Reaction Volume 50 µl 
 
 Dispense in PCR tubes. Reaction should be assembled on ice. 
 Add template DNA. 
 Place in thermal cycler as follows 
Reaction Time Temperature 
Initial Denaturation 3 minutes 94°C 
3 step cycling 
         Denaturation           
 
30 seconds 
 
94°C 
    Annealing 30 seconds 55°C 
    Extension 1 minute 72°C 
Number of cycles 40  
Final Extension 5 minutes 72°C 
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Appendix F 
Protocol for Promega’s Wizard SV gel and PCR Clean-Up System 
 Transfer the PCR product to SV Minicolumn assembly and incubate at room 
temperature for 1 minute. 
 Centrifuge the assembly in a microcentrifuge at 16,000 * g (14,000 rpm) for 1 
minute.  Discard the flow through and reassemble the SV Minicolumn and 
collection tube. 
 Wash the column with 700 µl of Membrane Wash Solution and centrifuge for 1 
minute at 16,000 * g.  Empty the wash through and repeat the wash with 500 µl of 
Membrane Wash Solution and centrifuge the assembly for 5 minutes at 16,000 * 
g. 
 Empty the collection tube and reassemble the column assembly.  Recentrifuge  for 
1 minute with microcentrifuge lid open to evaporate any residual liquid. 
 Transfer the SV Minicolumn to a sterile 1.5 ml microcentrifuge tube and add 50 
µl of nuclease free water.  Incubate at room temperature for 1 minute. Centrifuge 
at 16,000 * g for 1 minute. 
 Discard the SV Minicolumn and store the eluted DNA at 4 °C or -20 °C. 
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Appendix G 
Protocol for Roche’s In Vitro Transcription 
 Reaction was set up on ice as follows: 
 Experimental Positive Control Negative Control 
In Vitro 
Transcription 
Template 
TBX 5  DNA 
template (1 µg) 
at274.4 ng/ µl 
3.6 µl 
Ambion’s pTRI-
Actin Mouse at0.5 
µg/ µl) 
2 µl 
No DNA 
 
 
0 µl 
DEPC Treated DI 
Water 
6.4 µl 8 µl 10 µl 
5X Labeling Mix 
( Vial 1a) 
4 µl 4 µl 4 µl 
5X Transcription 
Buffer (Vial 1b) 
4 µl 4 µl 4 µl 
T7 RNA 
Polymerase 
2 µl 2 µl 2 µl 
Total reaction 
Volume 
20 µl 20 µl 20 µl 
 
 Centrifuge briefly and incubate at 30°C for 15 minutes. 
 Analyze on agarose gel to verify for the transcription product. 
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Appendix H 
Protocol for using Novagen’s Red Pellet Paint 
 Bring Pellet Paint Co-Precipitant and 3 M Na Acetate to room temperature.  
Invert Pellet Paint stock several times until uniform suspension is formed. 
 Add 2 µl Pellet Paint to RNA followed by 0.1 volumes of 3M Na Acetate.  Mix 
the sample. 
 Add 2 volume ethanol and vortex briefly.  Incubate the sample at room 
temperature for 10 minutes. 
  Spin the sample at 14,000 -16,000 * g in a microcentrifuge for 15 minutes. A 
pink pellet would be observed t the bottom of the tube. 
 Remove supernatant with a pipet tip. 
 Rinse pellet with 0.5 ml of 70% ethanol and spin again t 14,000- 16,000 * g for 10 
minutes. 
 Remove supernatant and rinse the pellet again with 0.5 ml of 100% ethanol.  Spin 
at 14,000- 16,000 * g for 10 minutes. 
 Remove the residual alcohol by vacuum drying. 
 Resuspend the pink pellet in 50 µl of DI water. 
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Appendix I 
Protocol for Mirus’s Label IT Nucleic Acid Labeling Kit: 
 Bring the Label IT vial to room temperature before use.  Add the Reconstitution 
buffer to the pellet in the vial. 
 Assemble the reaction as follows: 
Reagent Volume 
Molecular Biology Grade water 11.78 µl 
10X Labeling Buffer A 5 µl 
Nucleic Acid Sample at 274.4 ng/ µl 18.22 µl 
Label It Reagent 5 µl 
Total Reaction Volume 40 µl 
 Incubate the reaction at 37° C for 1 hour.  Spin the reaction after 30 minutes 
of incubation. 
 Purify the reaction by microspin column purification. 
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Appendix J 
 
Protocol for Dot Blot Assay to check for the Labeling Efficiency (Roche) 
- 10 fold serial dilution series of Dig labeled DNA by Mirus Label IT was 
prepared starting from 1/10 diluted DNA till 1/10^7. 
- 1 µl of the prepared diluents were applied to positively charged nylon 
membrane. 
- DNA was cross linked to the nylon membrane by baking for 1hour at 80°C. 
- Membrane was transferred to plastic container containing 20 ml washing 
buffer and incubated for 2 minutes at 20°C. 
- Membrane was incubated in 10 ml of blocking solution for 30 minutes. 
- Next membrane was incubated in 10ml of antibody solution for 30 minutes. 
- Membrane was washed twice in 20ml of washing buffer for 15 minutes each. 
- Membrane was placed in 10 ml of detection buffer for 5 minutes. 
- Membrane with the DNA side up was placed on a developing folder and 
1:10,000 diluted anti Dig AP were applied. Care was taken to immediately 
cover the membrane with another membrane for even distribution of the 
substrate while avoiding air bubbles. 
- Membrane was incubated overnight at 4°C. 
- NBT/BCIP was used for color development. Membrane was incubated in dark 
and carefully monitored for color development. 
 
 
 
 
 
